Unfortunately Professor Andrew Pollard is unable to join us on Thursday but we are delighted to announce that Dr Matthew Snape will be speaking in his place.
No other large-scale health intervention can have as big an impact on child mortality as vaccination. Across the world millions of lives have been saved by innoculation, and in the past ten years the annual number of measles cases worldwide has dropped from one million to 200,000. But just as important as creating new vaccines is ensuring that children have access to them. Join us at the Oxford Martin School as Dr Matthew Snape, Consultant in Vaccinology and General Paediatrics at the Oxford Radcliffe Hospitals NHS trust and an Honorary Senior Clinical Lecturer at the University of Oxford, looks at the challenges involved in making sure the success story of childhood vaccination can be a global one.
Join in on twitter with #c21health
This seminar will be live webcast on YouTube: https://www.youtube.com/watch?v=0CO2L5Rq7tU
About the speaker
Dr Matthew Snape is Consultant in Vaccinology and General Paediatrics at the Oxford Radcliffe Hospitals NHS trust and is an Honorary Senior Clinical Lecturer with the University of Oxford. After completing basic training in paediatrics at the Royal Children's Hospital, Melbourne, he spent 18 months working in the paediatric intensive care unit at St Mary's Hospital, London. While caring for children suffering overwhelming infections on this unit he developed an interest in the prevention of these illnesses by immunisation. This led him to the Oxford Vaccine Group, where he is currently the principal investigator on paediatric studies of meningococcal, pneumococcal, influenza and Hepatitis B vaccines. He has co-authored over 50 articles related to these areas in journals such as the Journal of the American Medical Association (JAMA), the British Medical Journal and the Lancet. He also continues to work in both inpatient and outpatient general paediatrics at the John Radcliffe Hospital. Dr Snape’s position is funded by the Oxford Partnership Biomedical Research Centre.